DE2900315C2 - 3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung - Google Patents

3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung

Info

Publication number
DE2900315C2
DE2900315C2 DE2900315A DE2900315A DE2900315C2 DE 2900315 C2 DE2900315 C2 DE 2900315C2 DE 2900315 A DE2900315 A DE 2900315A DE 2900315 A DE2900315 A DE 2900315A DE 2900315 C2 DE2900315 C2 DE 2900315C2
Authority
DE
Germany
Prior art keywords
compound
methyl
kanamycin
micromonospora
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2900315A
Other languages
German (de)
English (en)
Other versions
DE2900315A1 (de
Inventor
Hitoshi Ageo Saitama Ishida
Moto Niiza Saitama Morioka
Yoso Ageo Saitama Numasaki
Yoshihiko Kawagoe Saitama Oka
Takashi Osono
Hamao Tokio/Tokyo Umezawa
Tsutomu Yamafuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Microbial Chemistry Research Foundation
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation, Yamanouchi Pharmaceutical Co Ltd filed Critical Microbial Chemistry Research Foundation
Publication of DE2900315A1 publication Critical patent/DE2900315A1/de
Application granted granted Critical
Publication of DE2900315C2 publication Critical patent/DE2900315C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/46—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
    • C12P19/48—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin
    • C12P19/485—Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/29—Micromonospora
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/867—Micromonospora

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2900315A 1978-01-13 1979-01-05 3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung Expired DE2900315C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53003188A JPS6030320B2 (ja) 1978-01-13 1978-01-13 新規抗生物質およびその製造法

Publications (2)

Publication Number Publication Date
DE2900315A1 DE2900315A1 (de) 1979-07-19
DE2900315C2 true DE2900315C2 (de) 1986-06-26

Family

ID=11550416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2900315A Expired DE2900315C2 (de) 1978-01-13 1979-01-05 3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung

Country Status (10)

Country Link
US (2) US4209511A (US06312121-20011106-C00033.png)
JP (1) JPS6030320B2 (US06312121-20011106-C00033.png)
AT (1) AT364881B (US06312121-20011106-C00033.png)
CA (1) CA1115224A (US06312121-20011106-C00033.png)
DE (1) DE2900315C2 (US06312121-20011106-C00033.png)
ES (1) ES476814A1 (US06312121-20011106-C00033.png)
FR (1) FR2414513B1 (US06312121-20011106-C00033.png)
GB (1) GB2012267B (US06312121-20011106-C00033.png)
IT (1) IT1118286B (US06312121-20011106-C00033.png)
NL (1) NL186699C (US06312121-20011106-C00033.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412068A (en) * 1981-06-08 1983-10-25 Sterling Drug Inc. Novel compounds of the gentamicin class
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2009152202A2 (en) * 2008-06-11 2009-12-17 Utah State University New aminoglycosides: synthesis and use as antifungals
US8865665B2 (en) 2010-12-14 2014-10-21 Utah State University Aminoglycosides: synthesis and use as antifungals
US9669044B2 (en) 2010-12-14 2017-06-06 Utah State University Aminoglycoside and azole compositions and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045298A (en) * 1972-05-27 1977-08-30 Abbott Laboratories Antibiotic XK-62-2 and process for production thereof
JPS5220991B2 (US06312121-20011106-C00033.png) * 1972-08-23 1977-06-07
LU70223A1 (US06312121-20011106-C00033.png) * 1973-06-05 1976-04-13
US4132846A (en) * 1974-03-07 1979-01-02 Abbott Laboratories 1-N-(α-Hydroxy-β-aminopropionyl) XK-62-2 and method of production thereof
US3982996A (en) * 1975-09-22 1976-09-28 Sterling Drug Inc. Process for preparing aminocyclitol antibiotics
NZ185515A (en) * 1976-10-28 1980-08-26 Abbott Lab Fortimicin d and ke from culturing micromonospora olivoasterospora

Also Published As

Publication number Publication date
NL186699B (nl) 1990-09-03
CA1115224A (en) 1981-12-29
FR2414513A1 (US06312121-20011106-C00033.png) 1979-08-10
ATA12879A (de) 1981-04-15
ES476814A1 (es) 1979-10-16
US4279997A (en) 1981-07-21
NL7900265A (nl) 1979-07-17
AT364881B (de) 1981-11-25
IT7967067A0 (it) 1979-01-12
GB2012267B (en) 1982-06-09
JPS6030320B2 (ja) 1985-07-16
NL186699C (nl) 1991-02-01
JPS5498741A (en) 1979-08-03
DE2900315A1 (de) 1979-07-19
US4209511A (en) 1980-06-24
GB2012267A (en) 1979-07-25
FR2414513B1 (US06312121-20011106-C00033.png) 1980-09-19
IT1118286B (it) 1986-02-24

Similar Documents

Publication Publication Date Title
DE2435160C3 (de) Fortimicin A und dessen pharmakologisch verträgliche Säureadditionssalze sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE2532568C3 (de) Aclacinomycin A und B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2743654C3 (US06312121-20011106-C00033.png)
CH630957A5 (de) Verfahren zur herstellung von neuen antibiotischen verbindungen auf basis eines bohemsaeurekomplexes.
DE60006690T2 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
DE2900315C2 (de) 3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2904186C2 (de) Anthracyclin-Glykoside, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE2715255C3 (de) Anthracyclinglykoside MA 144-M, und MA 144-M2 und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE60110908T2 (de) Antibiotische tripropeptine und verfahren ihrer herstellung
AT392971B (de) Verfahren zur herstellung neuer antitumor-antibiotika
DE2004686C3 (de) Makrolid-Antibioticum SF-837 und dessen Diacetylderivat und deren pharmakologisch nichtgiftige Säureanlagerungssalze sowie Verfahren zur Herstellung des Antibioticums SF-837
DE2839668C2 (US06312121-20011106-C00033.png)
DE3012014C2 (de) Istamycine, Verfahren zu deren Herstellung sowie Verwendung derselben als antibakterielle Mittel
CH630958A5 (de) Verfahren zur herstellung von rhodirubin a und rhodirubin b.
DE3003624A1 (de) Antibiotica c-19393 s tief 2 und h tief 2
CH634853A5 (de) Schwefelhaltige metabolite, ihre herstellung und verwendung in arznei- und futtermitteln.
DE2418349C3 (de) Fortimicin B und dessen pharmakologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und Arzneimittel enthaltend diese Verbindungen
DE2928373C2 (de) Antibiotika KA-7038I bis KA-7038VII, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibiotische Mittel
DE2344780A1 (de) Antibiotikum xk-49-1-b-2, verfahren zu seiner herstellung auf mikrobiologischem wege und arzneipraeparate
DE2908150C2 (de) Fortimicin KG↓1↓, KG↓2↓ und KG↓3↓ Verfahren zu ihrerHerstellung und pharmazeutische Zubereitung
DE2950980A1 (de) Antibiotikum bn-183b, verfahren zu dessen herstellung und arzneimittel, welche dieses enthalten
DE2738656C2 (US06312121-20011106-C00033.png)
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung
DE2818544A1 (de) Antibiotikum sf-1942, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das antibiotikum sf-1942 enthaelt

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee